Open AccessCD47 is a Potential Target for the Treatment of Laryngeal Squamous Cell Carcinoma
Author(s) -
Chunping Yang,
Shufeng Gao,
Haizhen Zhang,
Lian Xu,
Jianguo Liu,
Meiqun Wang,
ShaoRong Zhang
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000452530
Subject(s) - cd47 , monoclonal antibody , cancer research , transfection , cell , antibody , in vivo , biology , cell culture , immunology , biochemistry , genetics , microbiology and biotechnology
This study aims to investigate the effect of CD47 on the development of laryngeal squamous cell carcinoma (LSCC) and the therapeutic potential of monoclonal antibody against CD47 and its ligand SIRPα in the treatment of LSCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom